A Study of HS-10506 in Chinese Patients With Insomnia Disorder

Summary

The primary purpose of this phase 3 study is to evaluate the safety and the efficacy of HS-10506 (change versus placebo) on latency to persistent sleep (LPS) and wakefulness after sleep onset (WASO) measured by polysomnography (PSG) in Chinese adult participants with insomnia disorder.

Timeline

Start

2026-05-29

Primary completion

2028-06-28

Completion

2028-08-12

Drugs

Indications